nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA6—ear—ocular cancer	0.137	0.183	CbGeAlD
Topiramate—GRIA4—eye—ocular cancer	0.0828	0.111	CbGeAlD
Topiramate—GRIA4—retina—ocular cancer	0.0821	0.11	CbGeAlD
Topiramate—GRIK3—retina—ocular cancer	0.0757	0.101	CbGeAlD
Topiramate—GRIK1—eye—ocular cancer	0.0726	0.0972	CbGeAlD
Topiramate—GRIK1—retina—ocular cancer	0.072	0.0963	CbGeAlD
Topiramate—GRIA1—eye—ocular cancer	0.036	0.0483	CbGeAlD
Topiramate—GRIA1—retina—ocular cancer	0.0357	0.0478	CbGeAlD
Topiramate—GRIK2—eye—ocular cancer	0.0259	0.0346	CbGeAlD
Topiramate—GRIK2—retina—ocular cancer	0.0256	0.0343	CbGeAlD
Topiramate—CA12—eye—ocular cancer	0.0242	0.0324	CbGeAlD
Topiramate—CA1—eye—ocular cancer	0.0191	0.0256	CbGeAlD
Topiramate—CA1—lymphoid tissue—ocular cancer	0.0135	0.0181	CbGeAlD
Topiramate—CA2—eye—ocular cancer	0.0124	0.0166	CbGeAlD
Topiramate—CA2—retina—ocular cancer	0.0123	0.0165	CbGeAlD
Topiramate—CA2—epithelium—ocular cancer	0.0114	0.0152	CbGeAlD
Topiramate—GRIA3—BDNF signaling pathway—CRTC1—ocular cancer	0.0113	0.0446	CbGpPWpGaD
Topiramate—GRIA4—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—ocular cancer	0.0101	0.0401	CbGpPWpGaD
Topiramate—CA2—lymphoid tissue—ocular cancer	0.00874	0.0117	CbGeAlD
Topiramate—CA9—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00867	0.0343	CbGpPWpGaD
Topiramate—GRIA3—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—ocular cancer	0.00736	0.0291	CbGpPWpGaD
Topiramate—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—ocular cancer	0.00714	0.0282	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CRTC1—ocular cancer	0.00676	0.0267	CbGpPWpGaD
Topiramate—GRIA1—Mecp2 and Associated Rett Syndrome—E2F1—ocular cancer	0.00501	0.0198	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CRTC1—ocular cancer	0.00473	0.0187	CbGpPWpGaD
Topiramate—GRIA1—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—ocular cancer	0.00441	0.0174	CbGpPWpGaD
Topiramate—GRIA4—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.00433	0.0171	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDK6—ocular cancer	0.00397	0.0157	CbGpPWpGaD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00374	0.0148	CbGpPWpGaD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00374	0.0148	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00348	0.0137	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00348	0.0137	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN2C—ocular cancer	0.00321	0.0127	CbGpPWpGaD
Topiramate—CA9—Cellular response to hypoxia—EP300—ocular cancer	0.00315	0.0125	CbGpPWpGaD
Topiramate—GRIA3—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.00315	0.0124	CbGpPWpGaD
Topiramate—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—ocular cancer	0.00308	0.0122	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—H1F0—ocular cancer	0.00302	0.0119	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00295	0.0117	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00281	0.0111	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00281	0.0111	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00261	0.0103	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00261	0.0103	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—E2F2—ocular cancer	0.00256	0.0101	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—E2F3—ocular cancer	0.00222	0.00879	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—RBBP4—ocular cancer	0.00222	0.00879	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00222	0.00878	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—MDM2—ocular cancer	0.00215	0.00851	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—MDM2—ocular cancer	0.00215	0.00851	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00215	0.00849	CbGpPWpGaD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—ocular cancer	0.00209	0.00828	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TFDP1—ocular cancer	0.00207	0.00817	CbGpPWpGaD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00205	0.00811	CbGpPWpGaD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00205	0.00811	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—MDM2—ocular cancer	0.002	0.00791	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—MDM2—ocular cancer	0.002	0.00791	CbGpPWpGaD
Topiramate—CA6—Metabolism—PSPH—ocular cancer	0.00197	0.00778	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PSPH—ocular cancer	0.00197	0.00778	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00191	0.00754	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00191	0.00754	CbGpPWpGaD
Topiramate—GRIA1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.00189	0.00745	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PSPH—ocular cancer	0.00184	0.00726	CbGpPWpGaD
Topiramate—CA7—Metabolism—PSPH—ocular cancer	0.00184	0.00726	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—MDM2—ocular cancer	0.0017	0.00673	CbGpPWpGaD
Topiramate—CA12—Metabolism—PSPH—ocular cancer	0.0017	0.00673	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00162	0.00641	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—MDM2—ocular cancer	0.00161	0.00638	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN1B—ocular cancer	0.00155	0.00612	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00154	0.0061	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00154	0.0061	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00151	0.00598	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CCND1—ocular cancer	0.00148	0.00584	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00145	0.00573	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00143	0.00567	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00143	0.00567	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN1A—ocular cancer	0.00143	0.00565	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDK6—ocular cancer	0.0014	0.00552	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—EP300—ocular cancer	0.00136	0.00538	CbGpPWpGaD
Topiramate—CA4—Metabolism—PSPH—ocular cancer	0.00136	0.00536	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CCND3—ocular cancer	0.00133	0.00528	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ocular cancer	0.00132	0.00521	CbGpPWpGaD
Topiramate—CA2—Metabolism—PSPH—ocular cancer	0.0013	0.00514	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00129	0.00508	CbGpPWpGaD
Topiramate—CA1—Metabolism—PSPH—ocular cancer	0.00125	0.00493	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—TGFB1—ocular cancer	0.00124	0.00491	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—MDM2—ocular cancer	0.00124	0.00489	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—HRAS—ocular cancer	0.00122	0.00482	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—MYC—ocular cancer	0.00119	0.00469	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—HRAS—ocular cancer	0.00118	0.00467	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—HRAS—ocular cancer	0.00118	0.00467	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00118	0.00466	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00118	0.00465	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—HRAS—ocular cancer	0.00115	0.00455	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—HRAS—ocular cancer	0.0011	0.00434	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—HRAS—ocular cancer	0.0011	0.00434	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSPH—ocular cancer	0.0011	0.00433	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN2B—ocular cancer	0.00108	0.00425	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—AKT1—ocular cancer	0.00102	0.00402	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.000996	0.00394	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—E2F1—ocular cancer	0.000988	0.0039	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000967	0.00382	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CCND3—ocular cancer	0.000938	0.00371	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—HRAS—ocular cancer	0.000934	0.00369	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—HRAS—ocular cancer	0.000931	0.00368	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.0009	0.00356	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000886	0.0035	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000884	0.0035	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000877	0.00347	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDK2—ocular cancer	0.000852	0.00337	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDK4—ocular cancer	0.000805	0.00318	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—MDM2—ocular cancer	0.000741	0.00293	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000706	0.00279	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—RB1—ocular cancer	0.0007	0.00277	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—HRAS—ocular cancer	0.00069	0.00273	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—HRAS—ocular cancer	0.000679	0.00268	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—MDM2—ocular cancer	0.000678	0.00268	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000676	0.00267	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.000676	0.00267	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000645	0.00255	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GNA11—ocular cancer	0.000619	0.00245	CbGpPWpGaD
Topiramate—CA6—Metabolism—GNA11—ocular cancer	0.000619	0.00245	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.000618	0.00244	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—AKT1—ocular cancer	0.000609	0.00241	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000603	0.00238	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—MDM2—ocular cancer	0.000597	0.00236	CbGpPWpGaD
Topiramate—CA7—Metabolism—GNA11—ocular cancer	0.000578	0.00229	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GNA11—ocular cancer	0.000578	0.00229	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GNAQ—ocular cancer	0.000576	0.00228	CbGpPWpGaD
Topiramate—CA6—Metabolism—GNAQ—ocular cancer	0.000576	0.00228	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CDK4—ocular cancer	0.000574	0.00227	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN1B—ocular cancer	0.000545	0.00215	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—ocular cancer	0.00054	0.00213	CbGpPWpGaD
Topiramate—CA7—Metabolism—GNAQ—ocular cancer	0.000537	0.00212	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GNAQ—ocular cancer	0.000537	0.00212	CbGpPWpGaD
Topiramate—CA12—Metabolism—GNA11—ocular cancer	0.000536	0.00212	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000531	0.0021	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MDM2—ocular cancer	0.000518	0.00205	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000508	0.00201	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN1A—ocular cancer	0.000503	0.00199	CbGpPWpGaD
Topiramate—CA12—Metabolism—GNAQ—ocular cancer	0.000498	0.00197	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000494	0.00195	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000485	0.00192	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—HRAS—ocular cancer	0.000483	0.00191	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—EP300—ocular cancer	0.000479	0.00189	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000465	0.00184	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNA11—ocular cancer	0.000427	0.00169	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—AKT1—ocular cancer	0.000426	0.00168	CbGpPWpGaD
Topiramate—CA2—Metabolism—GNA11—ocular cancer	0.000409	0.00162	CbGpPWpGaD
Topiramate—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000407	0.00161	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—HRAS—ocular cancer	0.000407	0.00161	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000406	0.0016	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CDK4—ocular cancer	0.000403	0.00159	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000397	0.00157	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNAQ—ocular cancer	0.000397	0.00157	CbGpPWpGaD
Topiramate—CA1—Metabolism—GNA11—ocular cancer	0.000393	0.00155	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MDM2—ocular cancer	0.000389	0.00154	CbGpPWpGaD
Topiramate—CA2—Metabolism—GNAQ—ocular cancer	0.000381	0.0015	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—HRAS—ocular cancer	0.000372	0.00147	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000371	0.00147	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000371	0.00147	CbGpPWpGaD
Topiramate—CA1—Metabolism—GNAQ—ocular cancer	0.000365	0.00144	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MDM2—ocular cancer	0.000356	0.00141	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNA11—ocular cancer	0.000345	0.00136	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—ocular cancer	0.000342	0.00135	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EP300—ocular cancer	0.000341	0.00135	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000339	0.00134	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—ocular cancer	0.000327	0.00129	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNAQ—ocular cancer	0.000321	0.00127	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MDM2—ocular cancer	0.000311	0.00123	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSPH—ocular cancer	0.000307	0.00121	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.000296	0.00117	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—ocular cancer	0.000296	0.00117	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—ocular cancer	0.000284	0.00112	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000279	0.0011	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000255	0.00101	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EP300—ocular cancer	0.00024	0.000947	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—ocular cancer	0.000233	0.000922	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—ocular cancer	0.00023	0.000909	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000223	0.000881	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—ocular cancer	0.000214	0.000844	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—ocular cancer	0.000208	0.000824	CbGpPWpGaD
Topiramate—CA6—Metabolism—EP300—ocular cancer	0.000207	0.000818	CbGpPWpGaD
Topiramate—CA5A—Metabolism—EP300—ocular cancer	0.000207	0.000818	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—ocular cancer	0.000206	0.000814	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—ocular cancer	0.000195	0.000772	CbGpPWpGaD
Topiramate—CA5B—Metabolism—EP300—ocular cancer	0.000193	0.000763	CbGpPWpGaD
Topiramate—CA7—Metabolism—EP300—ocular cancer	0.000193	0.000763	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSPH—ocular cancer	0.000185	0.00073	CbGpPWpGaD
Topiramate—CA12—Metabolism—EP300—ocular cancer	0.000179	0.000707	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—ocular cancer	0.000171	0.000675	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—ocular cancer	0.000164	0.000648	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—ocular cancer	0.000145	0.000573	CbGpPWpGaD
Topiramate—CA4—Metabolism—EP300—ocular cancer	0.000143	0.000564	CbGpPWpGaD
Topiramate—CA2—Metabolism—EP300—ocular cancer	0.000137	0.000541	CbGpPWpGaD
Topiramate—CA1—Metabolism—EP300—ocular cancer	0.000131	0.000518	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—ocular cancer	0.000125	0.000494	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—ocular cancer	0.000125	0.000494	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—ocular cancer	0.000117	0.000461	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—ocular cancer	0.000117	0.000461	CbGpPWpGaD
Topiramate—CA9—Metabolism—EP300—ocular cancer	0.000115	0.000456	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—ocular cancer	0.000108	0.000427	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNA11—ocular cancer	9.66e-05	0.000382	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNAQ—ocular cancer	8.98e-05	0.000355	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—ocular cancer	8.62e-05	0.000341	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—ocular cancer	8.27e-05	0.000327	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—ocular cancer	7.93e-05	0.000313	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.25e-05	0.000286	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—ocular cancer	6.97e-05	0.000275	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNA11—ocular cancer	5.81e-05	0.00023	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNAQ—ocular cancer	5.4e-05	0.000214	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EP300—ocular cancer	3.23e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—ocular cancer	1.95e-05	7.71e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EP300—ocular cancer	1.94e-05	7.67e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—ocular cancer	1.17e-05	4.64e-05	CbGpPWpGaD
